Pharmaceutical dose form grouper concepts specifying "infusion and/or injection" are modeled using General Concept Inclusions (GCIs).
For example,
- 1208958005 |Conventional release solution for infusion and/or injection (dose form)|
- 1236769008 |Gas for conventional release dispersion for infusion and/or injection (dose form)|
- 1237269000 |Concentrate for conventional release solution for infusion and/or injection (dose form)|
The following are out of scope for the international release but can be added to national extensions, concepts that specify:
- "infusion or injection"
- "infusion and injection"
Clinical drugs with infusion and/or injection
Clinical drugs modeled using pharmaceutical dose form groupers for “infusion and/or injection” are in scope for the International Release.
For example,
- 1252729004 |Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)| is modeled with |Has manufactured dose form (attribute)| of |Conventional release solution for infusion and/or injection (dose form)|.
Figure 1: Stated view of 1252729004 |Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)|
In cases where corresponding clinical drugs for both injection and infusion exist, the grouper for “infusion and/or injection” should be created. In other words, when creating a new clinical drug for infusion and an existing injection concept exists with the same substance and strength, then the grouper "for infusion and/or injection" should be created.
For example,
Feedback
Overview
Content Tools
Apps